Your Messages Inbox
Your Article Summary
See Latest ArticlesFDA approves Cervarix, GlaxoSmithKlines cervical cancer vaccine
GlaxoSmithKline, 10/19/09
GlaxoSmithKline announced that the U.S. Food and Drug Administration has approved CERVARIX for the prevention of cervical pre–cancers and cervical cancer associated with oncogenic human papillomavirus types 16 and 18 for use in girls and young women.
Today in Drug/Product Approvals...keeping you current
Receive free subspecialty "5-minute updates" via email
Gilead and GlaxoSmithKline Announce Agreement to Commercialize Viread(R) for Chronic Hepatitis B in Key Asian Countries
Gilead, 11/25/09
Boston Scientific Announces FDA Clearance and CE Mark for WallFlex Fully Covered Esophageal Stent
Boston Scientific, 11/24/09
AstraZeneca submits US New Drug Application for ticagrelor, an investigational antiplatelet agent
AstraZeneca, 11/23/09
Article Search
Sponsor